Mirum Pharmaceuticals, Inc. (MIRM) income statement
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$92.49+0.54 (+0.59%)
Close on Nov 18, 2026Market cap $6.01BP/E –Yield –
Mirum Pharmaceuticals, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -134.9%
- Net margin
- -139.2%
- Return on equity, FY2025
- -8.6%
Financial strength
- Current ratio
- 2.86
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 148.4%
Valuation
- P/E ratio
- –
- Price to sales
- 9.72
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?